Published in PLoS One on September 19, 2014
The immunological effect of hyaluronan in tumor angiogenesis. Clin Transl Immunology (2015) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Dendritic cells and the control of immunity. Nature (1998) 56.54
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med (2010) 29.75
Taking dendritic cells into medicine. Nature (2007) 11.82
SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol (2007) 6.89
Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol (2004) 6.83
Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 6.47
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med (1998) 6.12
Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol (2005) 5.80
Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med (2002) 5.70
Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J Exp Med (2003) 4.64
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol (2001) 3.45
Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol (2006) 3.32
Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev (2001) 3.27
Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest (1996) 2.86
Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem (2004) 2.81
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood (2002) 2.61
Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma. Cancer Res (2010) 2.61
Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state. Cancer Res (2003) 2.32
Mechanisms and consequences of dendritic cell migration. Immunity (2008) 2.25
Dendritic cells as vectors for therapy. Cell (2001) 2.18
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol (1997) 2.15
The promise of cancer vaccines. Nat Rev Cancer (2004) 1.92
Hyaluronan binding by cell surface CD44. J Biol Chem (2000) 1.86
Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages. J Exp Med (1996) 1.75
Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res (1999) 1.73
Hyaluronan fragments induce nitric-oxide synthase in murine macrophages through a nuclear factor kappaB-dependent mechanism. J Biol Chem (1997) 1.65
Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol (2003) 1.61
The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues. Immunol Rev (2000) 1.61
Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol (2000) 1.60
Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J Immunol (2002) 1.49
Different cross-presentation pathways in steady-state and inflammatory dendritic cells. Proc Natl Acad Sci U S A (2009) 1.46
A critical role for prostaglandin E2 in podosome dissolution and induction of high-speed migration during dendritic cell maturation. J Immunol (2006) 1.37
Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest (2004) 1.37
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients. Clin Cancer Res (2011) 1.29
The hyaluronan receptor, CD44. Int J Biochem Cell Biol (2002) 1.28
Low molecular weight hyaluronan from stretched lung enhances interleukin-8 expression. Am J Respir Cell Mol Biol (2003) 1.23
Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells. Cancer Immunol Immunother (2012) 1.19
Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci (2003) 1.17
Hyaluronan fragments induce cytokine and metalloprotease upregulation in human melanoma cells in part by signalling via TLR4. Exp Dermatol (2007) 1.17
How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev (2008) 1.15
Migration of dendritic cell based cancer vaccines: in vivo veritas? Curr Opin Immunol (2005) 1.11
Maximizing dendritic cell migration in cancer immunotherapy. Expert Opin Biol Ther (2008) 1.11
Chemokines and dendritic cell traffic. J Clin Immunol (2000) 1.08
Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccines. Cancer Immunol Immunother (2009) 1.04
Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer (2005) 1.01
Immunologic roles of hyaluronan. Immunol Res (2005) 1.00
Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation. J Immunol (2001) 0.98
Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. Biochem Biophys Res Commun (2000) 0.95
Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood (2006) 0.93
Role of CD44 and hyaluronic acid (HA) in activation of alloreactive and antigen-specific T cells by bone marrow-derived dendritic cells. J Immunother (2003) 0.93
Hyaluronan receptors involved in cytokine induction in monocytes. Glycobiology (2008) 0.90
Impaired monocyte function in cancer patients: restoration with a cyclooxygenase-2 inhibitor. FASEB J (2002) 0.89
Effect of sodium butyrate on pro-matrix metalloproteinase-9 and -2 differential secretion in pediatric tumors and cell lines. J Exp Clin Cancer Res (2005) 0.85
Altered hyaluronan biosynthesis and cancer progression: an immunological perspective. Mini Rev Med Chem (2009) 0.83
Ultraviolet-B irradiation enhances melanoma cell motility via induction of autocrine interleukin 8 secretion. Exp Dermatol (2007) 0.82
Dendritic cell-based cancer vaccination: quo vadis? Expert Rev Vaccines (2008) 0.82
In vitro studies on the trafficking of dendritic cells through endothelial cells and extra-cellular matrix. Dev Immunol (2000) 0.80
Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells. Gene Ther (2011) 0.80
Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation. PLoS One (2011) 0.79
Dendritic cell maturation with poly(I:C)-based versus PGE2-based cytokine combinations results in differential functional characteristics relevant to clinical application. J Immunother (2008) 0.79
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma. Cancer Immunol Immunother (2011) 0.78
CD44-deficient mice do not exhibit impairment of epidermal Langerhans cell migration to lymph nodes after epicutaneous sensitization with protein. J Invest Dermatol (2010) 0.76